Blog / Archives
Healthcare Sector Snapshot- M&A Will Drive SMID Cap Biopharma now in a Rally Mode…Update-2…”Strait talk”
Update-2 4/17/26...When the market is up because oil is down and the Straits may be open soon what can we say? A green screen day in SMID biopharma. Added to Illumina (ILMN) long at $132,...
SMID Biotech Stocks Update to our Trading Model with BULL Market Intact…Update-2
Update-2 4/12/26...Will try to focus on Diagnosiics and Tools this week as Healthcare looked weak.. Hope for some clarity from Abbott (ABT) down 19.95% YTD, on Thursday. Look at Fidelity FSMEX down...
Healthcare Sector Watch after a Bad Week, but Biotech is still Tradeable…Update-4..biotech rally!
Update-4 ..4/2/26..uh oh back onto tariff talk again ! NOT good for the market. Tariffs aren't good for business in general. BUT with our WAR in Iran ,and AI they create more chaos. Update-3...
Healthcare Sector Review : Q1 2026 Cutbacks in Government Spending are Taking its Toll…Update-4
Update-4 The market continued in its sell-off to the Fifth Week as the WAR in Iran pervades all thinking.If crude is up then stocks will be down. The latest timeline for the War with Iran for any...
Follow Sector Rotation This Week in Midst of War with Iran…Update-5…MedTech
What is your portfolio allocation by sector?
Large Cap Biopharmaceuticals: Still a Core Position for Your Portfolio…Update-2
Update-2 3/6/26... After the close learned that UBS upgraded biopharma stocks. Will review the sector over the weekend. XBI turned green and flat not down at the close. The IBB found buyers at $167....
Late February Doldrums: A Week for Trading SMID Caps and Rebalancing…Update-3…sector watch biotech!
Update 3/1/26: Get ready to rebalance your portfolio with War in Iran. Precious metals, energy, materials and Aerospace/ Defense stocks can be an initial focus. Check futures at 6P PST Sunday...
Wild Week of Rotation: Sector Performance 2026…Update-3… 2/12/26…the AI effect!
Update-3 2/15/26...More rotation ahead or waiting for Trump " State of the Nation?". Biotech stocks peaked on1/22 with the XBI at the $131 handle and now at $122.86. Here are current sector trends...
Large Cap Biopharmaceuticals: A Core Position for a Healthcare Portfolio…Update-5…hot stock EVMN
Update-5 2/10...Evommune (EVMN) up over 70% to the $29 level on Ph.2 a proof of concept trial for moderate to severe atopic dermatitis. The Company completed an IPO at $16/sh in NOV. '25 for...
Healthcare Sector Review: Biopharma and Genomics are Strong
Healthcare Sector Review January 2026 This should be a good time to set markers in anticipation of earnings and after a sell-off in health insurance stocks as well as severe re-balancing in...